Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
4 years ago
Coronavirus
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
4 years ago
Cell/Gene Tx
Biotech founders sentenced to 1 year and 1 day for stealing Genentech secrets, lying to investors
4 years ago
People
Kansas court preliminarily approves Viatris' $264M EpiPen settlement
4 years ago
Pharma
House committee calls on DOJ to investigate companies' opioid settlement tax benefits
4 years ago
Pharma
Appeals court sides with Bristol Myers Squibb in years-long battle with investors over Opdivo fail
4 years ago
Pharma
California stem cell clinic to pay out $3.65M settlement to former patients for ineffective treatments
4 years ago
Federal bankruptcy judge approves Purdue Pharma and Sacklers' $6 billion opioid settlement
4 years ago
Pharma
CSL and Grifols sue US border patrol for blocking Mexican plasma donations
4 years ago
Cell/Gene Tx
Manufacturing
After coming out of bankruptcy, Mallinckrodt pays out $260M to settle Acthar Gel lawsuits
4 years ago
Pharma
AbbVie settles one of its final Humira biosimilar suits for another mid-2023 delayed entry
4 years ago
Pharma
Pushing back against Eli Lilly motion, federal judge sends years-long whistleblower case to trial
4 years ago
Pharma
SEC jumps into the FibroGen fiasco with a subpoena, probing cardio data manipulation
4 years ago
FDA+
Broad Institute lands major victory in CRISPR patent fight over UC Berkeley, Nobel winners
4 years ago
Cell/Gene Tx
Viatris agrees to pay $264M to settle EpiPen class action case
4 years ago
Pharma
Developers of a key mRNA delivery tech, seeking a piece of Moderna's Covid riches, sue for patent infringement
4 years ago
Pharma
Pfizer drops case against ex-staffer accused of stealing trade secrets — including details about Covid-19 vaccine
4 years ago
People
Pharma
Blatant abuse of Chapter 11? J&J says its use of 'Texas two-step' is all about fairness
4 years ago
Pharma
First page
Previous page
34
35
36
37